Draft Genome Sequence of Proteus mirabilis NO-051/03, Representative of a Multidrug-Resistant Clone Spreading in Europe and Expressing the CMY-16 AmpC-Type β-Lactamase | Zendy

Marco Maria D’Andrea | Zendy; Tommaso Giani | Zendy; Lucia Henrici De Angelis | Zendy; Nagaia Ciacci | Zendy; Marek Gniadkowski | Zendy; Vivì Miriagou | Zendy; Francesca Torricelli | Zendy; Gian María Rossolini | Zendy

Open Access

Draft Genome Sequence of Proteus mirabilis NO-051/03, Representative of a Multidrug-Resistant Clone Spreading in Europe and Expressing the CMY-16 AmpC-Type β-Lactamase

Author(s) -

Marco Maria D’Andrea,

Tommaso Giani,

Lucia Henrici De Angelis,

Nagaia Ciacci,

Marek Gniadkowski,

Vivì Miriagou,

Francesca Torricelli,

Gian María Rossolini

Publication year - 2016

Publication title -

genome announcements

Language(s) - English

Resource type - Journals

ISSN - 2169-8287

DOI - 10.1128/genomea.01702-15

Subject(s) - proteus mirabilis , biology , microbiology and biotechnology , multiple drug resistance , whole genome sequencing , clone (java method) , proteus , genome , gene , genetics , drug resistance , escherichia coli

Proteus mirabilis NO-051/03, representative of a multidrug-resistant clone expressing the CMY-16 AmpC-type β-lactamase and circulating in Europe since 2003, was sequenced by a MiSeq platform using a paired-end approach. The genome was assembled in 100 scaffolds with a total length of 4,197,318 bp. Analysis of the draft genome sequence revealed the presence of several acquired resistance determinants to β-lactams, aminoglycosides, phenicols, tetracyclines, trimethoprim, and sulfonamides, of one plasmid replicon, and of a type I-E clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein (Cas) adaptive immune system.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research